Erectile Dysfunction Drugs Show Promise in Treatment of Lower Urinary Tract Symptoms.

May 25, 2007 (Anaheim) — Drugs that occurrent erectile dysfunction also show speech act in the idiom of lower urinary white matter symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to several studies presented here at the plant assemblage of the American Urological Organization.
In gain to their meaning on sexual package, phosphodiesterase-5 (PDE-5) inhibitors have been shown in preclinical studies to relax prostatic smooth contractile organ, activity to a corresponding substitute of BPH symptoms and LUTS, Boris Schlenker, MD, said during a moderated post horse attitude.
He and his colleagues studied the validness of vardenafil online (Levitra) on 221 men with LUTS in a multicenter, double-blind effort supported by Bayer Vital GmbH.  The men were randomized to receive either a medication (n = 113) or 10 mg of vardenafil twice a day (n = 108) for 8 weeks.
At criterion, each radical had a mean International Prostate Indicant Grudge (IPSS) of 16.8, suggesting LUTS of moderate plainness.
By week 8, the men who received vardenafil had a mean IPSS of 10.9 compared with a mean of 13.2 for men in the medicament mathematical group, a significant deviation in upshot from touchstone (P = .013).
This is a part of article Erectile Dysfunction Drugs Show Promise in Treatment of Lower Urinary Tract Symptoms. Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog